HEADER TRANSFERASE 15-OCT-18 6HWV TITLE CRYSTAL STRUCTURE OF P38ALPHA IN COMPLEX WITH A PHOTOSWITCHABLE 2- TITLE 2 AZOIMIDAZOL-BASED INHIBITOR (COMPOUND 3) COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 14; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MAPK 14,CYTOKINE SUPPRESSIVE ANTI-INFLAMMATORY DRUG-BINDING COMPND 5 PROTEIN,CSBP,MAP KINASE MXI2,MAX-INTERACTING PROTEIN 2,MITOGEN- COMPND 6 ACTIVATED PROTEIN KINASE P38 ALPHA,MAP KINASE P38 ALPHA,STRESS- COMPND 7 ACTIVATED PROTEIN KINASE 2A,SAPK2A; COMPND 8 EC: 2.7.11.24; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS P38ALPHA, MAPK14, PHOTOSWITCHABLE, AZOTHIAZOL, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR M.P.MUELLER,D.RAUH REVDAT 4 24-JAN-24 6HWV 1 HETSYN REVDAT 3 29-JUL-20 6HWV 1 COMPND REMARK HETNAM SITE REVDAT 2 19-JUN-19 6HWV 1 JRNL REVDAT 1 17-APR-19 6HWV 0 JRNL AUTH M.SCHEHR,C.IANES,J.WEISNER,L.HEINTZE,M.P.MULLER,C.PICHLO, JRNL AUTH 2 J.CHARL,E.BRUNSTEIN,J.EWERT,M.LEHR,U.BAUMANN,D.RAUH, JRNL AUTH 3 U.KNIPPSCHILD,C.PEIFER,R.HERGES JRNL TITL 2-AZO-, 2-DIAZOCINE-THIAZOLS AND 2-AZO-IMIDAZOLES AS JRNL TITL 2 PHOTOSWITCHABLE KINASE INHIBITORS: LIMITATIONS AND PITFALLS JRNL TITL 3 OF THE PHOTOSWITCHABLE INHIBITOR APPROACH. JRNL REF PHOTOCHEM. PHOTOBIOL. SCI. V. 18 1398 2019 JRNL REFN ISSN 1474-9092 JRNL PMID 30924488 JRNL DOI 10.1039/C9PP00010K REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.10_2155: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 37.36 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 40463 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.181 REMARK 3 R VALUE (WORKING SET) : 0.180 REMARK 3 FREE R VALUE : 0.197 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2023 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 37.3640 - 4.0956 1.00 2925 154 0.1623 0.1496 REMARK 3 2 4.0956 - 3.2514 1.00 2809 148 0.1572 0.1863 REMARK 3 3 3.2514 - 2.8406 1.00 2773 146 0.1846 0.2068 REMARK 3 4 2.8406 - 2.5809 1.00 2757 145 0.1824 0.2113 REMARK 3 5 2.5809 - 2.3960 1.00 2741 145 0.1867 0.1894 REMARK 3 6 2.3960 - 2.2547 1.00 2743 144 0.1819 0.2202 REMARK 3 7 2.2547 - 2.1418 1.00 2728 144 0.1789 0.2117 REMARK 3 8 2.1418 - 2.0486 1.00 2731 143 0.1817 0.2132 REMARK 3 9 2.0486 - 1.9697 1.00 2704 143 0.1957 0.2084 REMARK 3 10 1.9697 - 1.9018 1.00 2723 142 0.2145 0.2618 REMARK 3 11 1.9018 - 1.8423 1.00 2702 142 0.2006 0.2109 REMARK 3 12 1.8423 - 1.7896 1.00 2688 142 0.2106 0.2346 REMARK 3 13 1.7896 - 1.7425 1.00 2730 144 0.2316 0.2596 REMARK 3 14 1.7425 - 1.7000 1.00 2686 141 0.2809 0.3096 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.180 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 21.880 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 2932 REMARK 3 ANGLE : 0.956 3984 REMARK 3 CHIRALITY : 0.054 447 REMARK 3 PLANARITY : 0.006 499 REMARK 3 DIHEDRAL : 13.960 1796 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: (CHAIN A AND RESSEQ 5:352) REMARK 3 ORIGIN FOR THE GROUP (A): -11.7282 -4.5177 18.1505 REMARK 3 T TENSOR REMARK 3 T11: 0.1153 T22: 0.0626 REMARK 3 T33: 0.0678 T12: 0.0171 REMARK 3 T13: -0.0080 T23: -0.0088 REMARK 3 L TENSOR REMARK 3 L11: 0.8642 L22: 0.5865 REMARK 3 L33: 0.5389 L12: 0.1219 REMARK 3 L13: 0.0225 L23: 0.0240 REMARK 3 S TENSOR REMARK 3 S11: 0.0093 S12: 0.0143 S13: 0.0247 REMARK 3 S21: 0.0155 S22: -0.0067 S23: 0.0009 REMARK 3 S31: -0.0730 S32: -0.0239 S33: -0.0004 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6HWV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 15-OCT-18. REMARK 100 THE DEPOSITION ID IS D_1200012301. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-FEB-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : PSI PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40470 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 49.100 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 13.10 REMARK 200 R MERGE (I) : 0.07800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 20.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.80 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 13.30 REMARK 200 R MERGE FOR SHELL (I) : 0.80800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5N63 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.42 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.17 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM MES PH 5.6-6.2, 20-30 % REMARK 280 PEG4000, 40MM BOG, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 34.50500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 37.35500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.99000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 37.35500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 34.50500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 34.99000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1580 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17150 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 16.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -1 REMARK 465 SER A 0 REMARK 465 HIS A 1 REMARK 465 SER A 2 REMARK 465 GLN A 3 REMARK 465 GLU A 4 REMARK 465 ARG A 173 REMARK 465 HIS A 174 REMARK 465 THR A 175 REMARK 465 ASP A 176 REMARK 465 ASP A 177 REMARK 465 GLU A 178 REMARK 465 MET A 179 REMARK 465 THR A 180 REMARK 465 GLY A 181 REMARK 465 TYR A 182 REMARK 465 VAL A 183 REMARK 465 ALA A 184 REMARK 465 LEU A 353 REMARK 465 ASP A 354 REMARK 465 GLN A 355 REMARK 465 GLU A 356 REMARK 465 GLU A 357 REMARK 465 MET A 358 REMARK 465 GLU A 359 REMARK 465 SER A 360 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 149 -9.79 80.00 REMARK 500 ARG A 149 -11.26 81.17 REMARK 500 ASP A 150 46.92 -146.09 REMARK 500 MET A 198 -172.43 63.29 REMARK 500 PHE A 274 49.08 -101.78 REMARK 500 REMARK 500 REMARK: NULL DBREF 6HWV A 2 360 UNP Q16539 MK14_HUMAN 2 360 SEQADV 6HWV GLY A -1 UNP Q16539 EXPRESSION TAG SEQADV 6HWV SER A 0 UNP Q16539 EXPRESSION TAG SEQADV 6HWV HIS A 1 UNP Q16539 EXPRESSION TAG SEQRES 1 A 362 GLY SER HIS SER GLN GLU ARG PRO THR PHE TYR ARG GLN SEQRES 2 A 362 GLU LEU ASN LYS THR ILE TRP GLU VAL PRO GLU ARG TYR SEQRES 3 A 362 GLN ASN LEU SER PRO VAL GLY SER GLY ALA TYR GLY SER SEQRES 4 A 362 VAL CYS ALA ALA PHE ASP THR LYS THR GLY LEU ARG VAL SEQRES 5 A 362 ALA VAL LYS LYS LEU SER ARG PRO PHE GLN SER ILE ILE SEQRES 6 A 362 HIS ALA LYS ARG THR TYR ARG GLU LEU ARG LEU LEU LYS SEQRES 7 A 362 HIS MET LYS HIS GLU ASN VAL ILE GLY LEU LEU ASP VAL SEQRES 8 A 362 PHE THR PRO ALA ARG SER LEU GLU GLU PHE ASN ASP VAL SEQRES 9 A 362 TYR LEU VAL THR HIS LEU MET GLY ALA ASP LEU ASN ASN SEQRES 10 A 362 ILE VAL LYS CYS GLN LYS LEU THR ASP ASP HIS VAL GLN SEQRES 11 A 362 PHE LEU ILE TYR GLN ILE LEU ARG GLY LEU LYS TYR ILE SEQRES 12 A 362 HIS SER ALA ASP ILE ILE HIS ARG ASP LEU LYS PRO SER SEQRES 13 A 362 ASN LEU ALA VAL ASN GLU ASP CYS GLU LEU LYS ILE LEU SEQRES 14 A 362 ASP PHE GLY LEU ALA ARG HIS THR ASP ASP GLU MET THR SEQRES 15 A 362 GLY TYR VAL ALA THR ARG TRP TYR ARG ALA PRO GLU ILE SEQRES 16 A 362 MET LEU ASN TRP MET HIS TYR ASN GLN THR VAL ASP ILE SEQRES 17 A 362 TRP SER VAL GLY CYS ILE MET ALA GLU LEU LEU THR GLY SEQRES 18 A 362 ARG THR LEU PHE PRO GLY THR ASP HIS ILE ASP GLN LEU SEQRES 19 A 362 LYS LEU ILE LEU ARG LEU VAL GLY THR PRO GLY ALA GLU SEQRES 20 A 362 LEU LEU LYS LYS ILE SER SER GLU SER ALA ARG ASN TYR SEQRES 21 A 362 ILE GLN SER LEU THR GLN MET PRO LYS MET ASN PHE ALA SEQRES 22 A 362 ASN VAL PHE ILE GLY ALA ASN PRO LEU ALA VAL ASP LEU SEQRES 23 A 362 LEU GLU LYS MET LEU VAL LEU ASP SER ASP LYS ARG ILE SEQRES 24 A 362 THR ALA ALA GLN ALA LEU ALA HIS ALA TYR PHE ALA GLN SEQRES 25 A 362 TYR HIS ASP PRO ASP ASP GLU PRO VAL ALA ASP PRO TYR SEQRES 26 A 362 ASP GLN SER PHE GLU SER ARG ASP LEU LEU ILE ASP GLU SEQRES 27 A 362 TRP LYS SER LEU THR TYR ASP GLU VAL ILE SER PHE VAL SEQRES 28 A 362 PRO PRO PRO LEU ASP GLN GLU GLU MET GLU SER HET BOG A 401 20 HET BOG A 402 20 HET BOG A 403 20 HET GEW A 404 43 HETNAM BOG OCTYL BETA-D-GLUCOPYRANOSIDE HETNAM GEW 3-(2,5-DIMETHOXYPHENYL)-~{N}-[4-[5-(4-FLUOROPHENYL)-2- HETNAM 2 GEW [(~{E})-(4-FLUOROPHENYL)DIAZENYL]-3-METHYL-IMIDAZOL-4- HETNAM 3 GEW YL]PYRIDIN-2-YL]PROPANAMIDE HETSYN BOG BETA-OCTYLGLUCOSIDE; OCTYL BETA-D-GLUCOSIDE; OCTYL D- HETSYN 2 BOG GLUCOSIDE; OCTYL GLUCOSIDE FORMUL 2 BOG 3(C14 H28 O6) FORMUL 5 GEW C32 H28 F2 N6 O3 FORMUL 6 HOH *270(H2 O) HELIX 1 AA1 SER A 61 MET A 78 1 18 HELIX 2 AA2 SER A 95 PHE A 99 5 5 HELIX 3 AA3 ASP A 112 LYS A 118 1 7 HELIX 4 AA4 THR A 123 ALA A 144 1 22 HELIX 5 AA5 LYS A 152 SER A 154 5 3 HELIX 6 AA6 ALA A 190 LEU A 195 1 6 HELIX 7 AA7 THR A 203 GLY A 219 1 17 HELIX 8 AA8 ASP A 227 GLY A 240 1 14 HELIX 9 AA9 GLY A 243 LYS A 248 1 6 HELIX 10 AB1 SER A 252 SER A 261 1 10 HELIX 11 AB2 ASN A 269 PHE A 274 1 6 HELIX 12 AB3 ASN A 278 LEU A 289 1 12 HELIX 13 AB4 ASP A 292 ARG A 296 5 5 HELIX 14 AB5 THR A 298 ALA A 304 1 7 HELIX 15 AB6 HIS A 305 ALA A 309 5 5 HELIX 16 AB7 GLN A 325 ARG A 330 5 6 HELIX 17 AB8 LEU A 333 SER A 347 1 15 SHEET 1 AA1 2 PHE A 8 LEU A 13 0 SHEET 2 AA1 2 THR A 16 PRO A 21 -1 O TRP A 18 N GLN A 11 SHEET 1 AA2 5 TYR A 24 GLY A 33 0 SHEET 2 AA2 5 GLY A 36 ASP A 43 -1 O VAL A 38 N GLY A 31 SHEET 3 AA2 5 LEU A 48 LEU A 55 -1 O VAL A 52 N CYS A 39 SHEET 4 AA2 5 TYR A 103 HIS A 107 -1 O LEU A 104 N LYS A 53 SHEET 5 AA2 5 ASP A 88 PHE A 90 -1 N ASP A 88 O VAL A 105 SHEET 1 AA3 2 LEU A 156 VAL A 158 0 SHEET 2 AA3 2 LEU A 164 ILE A 166 -1 O LYS A 165 N ALA A 157 CRYST1 69.010 69.980 74.710 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014491 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014290 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013385 0.00000